FCM
PCRX icon

Frontier Capital Management’s Pacira BioSciences PCRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,836,873
Closed -$52.6M 295
2024
Q2
$52.6M Sell
1,836,873
-77,470
-4% -$2.22M 0.52% 67
2024
Q1
$55.9M Sell
1,914,343
-170,199
-8% -$4.97M 0.52% 61
2023
Q4
$70.3M Buy
2,084,542
+285,045
+16% +$9.62M 0.71% 36
2023
Q3
$55.2M Buy
1,799,497
+114,242
+7% +$3.5M 0.61% 52
2023
Q2
$67.5M Buy
1,685,255
+81,171
+5% +$3.25M 0.65% 49
2023
Q1
$65.5M Buy
1,604,084
+542,661
+51% +$22.1M 0.68% 52
2022
Q4
$41M Sell
1,061,423
-73,564
-6% -$2.84M 0.45% 87
2022
Q3
$60.4M Buy
1,134,987
+72,320
+7% +$3.85M 0.71% 38
2022
Q2
$62M Buy
1,062,667
+7,945
+0.8% +$463K 0.71% 31
2022
Q1
$80.5M Buy
1,054,722
+124,851
+13% +$9.53M 0.73% 37
2021
Q4
$56M Buy
929,871
+135,927
+17% +$8.18M 0.44% 76
2021
Q3
$44.5M Sell
793,944
-18,129
-2% -$1.02M 0.35% 106
2021
Q2
$49.3M Sell
812,073
-226,302
-22% -$13.7M 0.36% 106
2021
Q1
$72.8M Buy
1,038,375
+6,178
+0.6% +$433K 0.55% 57
2020
Q4
$61.8M Sell
1,032,197
-51,901
-5% -$3.11M 0.46% 75
2020
Q3
$65.2M Sell
1,084,098
-20,593
-2% -$1.24M 0.57% 58
2020
Q2
$58M Buy
1,104,691
+25,019
+2% +$1.31M 0.51% 65
2020
Q1
$36.2M Sell
1,079,672
-269,977
-20% -$9.05M 0.41% 90
2019
Q4
$61.1M Sell
1,349,649
-328,835
-20% -$14.9M 0.45% 82
2019
Q3
$63.9M Buy
1,678,484
+63,613
+4% +$2.42M 0.5% 65
2019
Q2
$70.2M Buy
1,614,871
+235,246
+17% +$10.2M 0.53% 62
2019
Q1
$52.5M Buy
+1,379,625
New +$52.5M 0.37% 110
2017
Q3
Sell
-123,857
Closed -$5.91M 325
2017
Q2
$5.91M Sell
123,857
-3,058
-2% -$146K 0.04% 267
2017
Q1
$5.79M Buy
126,915
+48,179
+61% +$2.2M 0.04% 265
2016
Q4
$2.54M Sell
78,736
-5,012
-6% -$162K 0.02% 275
2016
Q3
$2.87M Sell
83,748
-18,496
-18% -$633K 0.02% 280
2016
Q2
$3.45M Sell
102,244
-63,218
-38% -$2.13M 0.03% 277
2016
Q1
$8.77M Sell
165,462
-24,284
-13% -$1.29M 0.07% 245
2015
Q4
$14.6M Buy
+189,746
New +$14.6M 0.12% 215